Lesions pose significant threat to vision

Primitive retinal vascular tumours and telangiectasias can cause significant visual impairment and accurate diagnosis is important in determining which treatment will be most appropriate in any particular case, according to a review of literature carried out by Karl Anders Knutsson MD and associates at the San Raffaele Scientific Institute, Milan, Italy. The authors noted that if these conditions are left untreated, chronic macular oedema and exudation can lead to drastic complications such as retinal detachment and consequent neovascular glaucoma. OCT findings aid the diagnosis of these conditions and offer important information regarding the disease and eventual therapeutic management. The current therapeutic strategies are aimed at reducing lesion growth, amount of exudation and to prevent or resolve complications. They include laser photocoagulation, intravitreal injection of anti-VEGF drugs, cry therapy and PDT.
(Knutsen et al, Ophthalmologica 2012; DOI: 10.1159/000338230.)Â
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.